Clonal diversity determines persistence of SARS-CoV-2 epitope-specific T cell response
Author:
Zornikova Ksenia V.ORCID, Khmelevskaya AlexandraORCID, Sheetikov Savely A.ORCID, Kiryukhin Dmitry O.ORCID, Shcherbakova Olga V.ORCID, Titov AlekseiORCID, Zvyagin Ivan V.ORCID, Efimov Grigory A.ORCID
Abstract
AbstractT cells play a pivotal role in reducing disease severity during SARS-CoV-2 infection and formation of long-term immune memory. We studied 50 COVID-19 convalescent patients and found that T cell response was induced more frequently and persisted longer than circulating antibodies. To identify epitopes that give rise to long-lived T cell memory, we performed ex vivo T cell expansion, MHC-tetramer cell-sorting, and high-throughput sequencing. We identified 756 clonotypes specific to nine known CD8+ T cell receptor (TCR) epitopes. Some epitopes were recognized by highly similar public clonotypes with restricted variable and joining segment usage. Receptors for other epitopes were extremely diverse, suggesting alternative modes of recognition. We also tracked persistence of epitope-specific response and individual clonotypes for a median of eight months after infection. The number of recognized epitopes per patient and quantity of epitope-specific clonotypes decreased over time, but the studied epitopes were characterized by uneven decline in the number of specific T cells. Epitopes with more clonally diverse TCR repertoires induced more pronounced and durable responses. In contrast, the abundance of specific clonotypes in peripheral circulation had no influence on their persistence. Our study demonstrates the durability of SARS-CoV-2-specific CD8+ memory, and offers important implications for vaccine design.
Publisher
Cold Spring Harbor Laboratory
Reference67 articles.
1. Adamo, S. , Michler, J. , Zurbuchen, Y. , Cervia, C. , Taeschler, P. , Raeber, M.E. , Sain, S.B. , Nilsson, J. , Moor, A.E. , Boyman, O. , 2021. Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection. Nature. https://doi.org/10.1038/s41586-021-04280-x 2. Agerer, B. , Koblischke, M. , Gudipati, V. , Montaño-Gutierrez, L.F. , Smyth, M. , Popa, A. , Genger, J.-W. , Endler, L. , Florian, D.M. , Mühlgrabner, V. , Graninger, M. , Aberle, S.W. , Husa, A.-M. , Shaw, L.E. , Lercher, A. , Gattinger, P. , Torralba-Gombau, R. , Trapin, D. , Penz, T. , Barreca, D. , Fae, I. , Wenda, S. , Traugott, M. , Walder, G. , Pickl, W.F. , Thiel, V. , Allerberger, F. , Stockinger, H. , Puchhammer-Stöckl, E. , Weninger, W. , Fischer, G. , Hoepler, W. , Pawelka, E. , Zoufaly, A. , Valenta, R. , Bock, C. , Paster, W. , Geyeregger, R. , Farlik, M. , Halbritter, F. , Huppa, J.B. , Aberle, J.H. , Bergthaler, A. , 2021. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses. Science Immunology 6. https://doi.org/10.1126/sciimmunol.abg6461 3. Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis;iScience,2021 4. VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium;Nucleic Acids Research,2019 5. Bilich, T. , Nelde, A. , Heitmann, J.S. , Maringer, Y. , Roerden, M. , Bauer, J. , Rieth, J. , Wacker, M. , Peter, A. , Hörber, S. , Rachfalski, D. , Märklin, M. , Stevanović, S. , Rammensee, H.-G. , Salih, H.R. , Walz, J.S. , 2021. T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals. Science Translational Medicine 13. https://doi.org/10.1126/scitranslmed.abf7517
|
|